← Evidence map

ArticleThoracic cancer2026

Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab.

Shotaro Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Clinicopathological Features of DLL3 Expression and T-Cell Infiltration in LCNEC: Insights From Pathology and Clinical Response to Tarlatamab. | OpenQuestion